Vivoryon Therapeutics N.V.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Vivoryon Therapeutics N.V. generated cash of -$21,541,000, which is more than the previous year. Cash used in financing activities reached the amount of $24,157,000 last year. Net change in cash is therefore -$7,993,000.
Cash Flow
| 2014 | -10.58K | 1.32K | 25.76K |
|---|---|---|---|
| 2015 | -12.14K | -10 | 12.59K |
| 2016 | -13.25K | -124 | 13.91K |
| 2017 | -12.11K | 459 | 127 |
| 2018 | -6.99K | 460 | 0 |
| 2019 | -11.60M | -47K | 49.35M |
| 2020 | -14.01M | -640K | -90K |
| 2021 | -11.25M | -28K | -827K |
| 2022 | -21.79M | -13K | 33.38M |
| 2023 | -21.54M | -10.51M | 24.15M |
0R3M.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 26.55M | 14.66M | 26.30M | 41.52M | 3.78M | 10.29K | 21.89K | 21.36K | 20.92K | 4.87K |
Operating activities | ||||||||||
Net income | -28.34M | -28.15M | -12.65M | -16.51M | -7.82M | -7.73K | -8.00K | -13.89K | -13.50K | -11.43K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 167K | 161K | 165K | 146K | 88K | 23 | 106 | 97 | 56 | 94 |
Stock-based compensation expense | 3.94M | 3.48M | 1.76M | 159K | 5K | 62K | 286K | 650K | 964K | 818 |
| Deferred income tax benefit | 3.94M | 3.48M | 1.76M | 159K | 5K | 62K | 286K | 650K | 964K | 818 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 538K | -1.81M | 3.44M | 372K | -233K | 418K | -1.54M | 264K | 570K | 0 |
Cash generated by operating activities | -21.54M | -21.79M | -11.25M | -14.01M | -11.60M | -6.99K | -12.11K | -13.25K | -12.14K | -10.58K |
Investing activities | ||||||||||
Purchases Of Investments | -19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -14K | -13K | -28K | -640K | -47K | -16 | -7 | -7 | -6 | -2 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -10.51M | -13K | -28K | -640K | -47K | 460 | 459 | -124 | -10 | 1.32K |
Financing activities | ||||||||||
Common Stock Issued | 26.34M | 36M | -737K | 0 | 51.23M | 0 | 127K | 13.91M | 13.53M | 23.24M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -90 | -90 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 24.15M | 33.38M | -827K | -90K | 49.35M | 0 | 127 | 13.91K | 12.59K | 25.76K |
Net Change In Cash | -7.99M | 11.89M | -11.64M | -15.21M | 37.74M | -6.50K | -11.60K | 536 | 441 | 16.04K |
Cash at end of period | 18.56M | 26.55M | 14.66M | 26.30M | 41.52M | 3.78K | 10.29K | 21.89K | 21.36K | 20.92K |